Vibrator Mesh Nebulizer Market Segmentation by Type (Active, and Passive Mesh Nebulizers); by Portability (Portable Mesh Nebulizers and Standalone Mesh Nebulizers); by Distribution Channel (Online, and Offline); and by End User (Hospitals, Clinics, Home Care Setting, Ambulatory Surgical Centers, and Others) – Global Demand Analysis and Opportunity Outlook 2021-2029
Buy Now
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022. Purchasing power in the country is expected to fell nearly by 2.5%.
On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.
The vibrator mesh nebulizer is estimated to grow with a moderate CAGR during the forecast period, i.e., 2021-2029. Extensive research associated with chronic respiratory conditions in western countries, along with the growing investments in the development of advanced mesh nebulizers that use lower-frequency waves, are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and the rising prevalence of respiratory disorders such as COPD, asthma and cystic fibrosis, and obstructive lung disorders, among individuals. According to the data collected from World Health Organization, more than 90% of COPD deaths are recorded in low-income and middle-income countries. This indicates that 3 million people die each year from COPD.
The market is segmented based on type into active mesh nebulizers and passive mesh nebulizers, out of which, the active mesh nebulizers segment is anticipated to grab the largest share by the end of 2029 on account of portability and better efficiency of active mesh nebulizers than the passive ones. Furthermore, active mesh nebulizers use a piezo feature that contracts and expands in response to an electric current and vibrates a precisely drilled mesh in contact with the drug in order to produce an aerosol, which is also projected to contribute to the growth of the segment during the forecast period. CLICK TO DOWNLOAD SAMPLE
On the basis of end user, the clinics segment in the market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the rising number of private respiratory clinics and the rise in the adoption of advanced technologies for respiratory care in clinics.
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa region. The market in North America is predicted to occupy the largest share over the forecast period owing to the well-developed healthcare infrastructure and technological advancement in the region. Along with this, adequate reimbursement policies for these devices also boost the market growth in the region. Furthermore, the market in the Asia Pacific is expected to be the fastest-growing region, owing to the rising awareness regarding the application of vibrator mesh nebulizers and increasing geriatric population coupled with high cases of chronic respiratory disorders.
According to the Centers for Disease Control and Prevention (CDC), every 1 in 13 suffering from asthma in the country. The high prevalence of COPD and asthma in children and adults propel the demand for vibrator mesh nebulizer in the U.S.
The global vibrator mesh nebulizer market is further classified on the basis of region as follows:
Our in-depth analysis of the global vibrator mesh nebulizer market includes the following segments:
Ans: Rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis are the key factors driving market growth.
Ans: The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.
Ans: Presence of substitutes for treatment are estimated to hamper market growth.
Ans: The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about vibrator mesh nebulizer and rising geriatric population in the region.
Ans: The major players dominating the vibrating mesh nebulizer market are Pfizer Inc., Bayer AG, Astellas Pharma US, Inc., and Merck Sharp & Dohme Corp. among others.
Ans: The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by type, portability, distribution channels, end-users and region.
Ans: With respect to end-user, the clinics segment is anticipated to hold the largest market share owing to the rising number of private respiratory care clinics.
Submit Your Request For Proposal (RFP)
Submit RFP Buy Now Download Research Report Sample
